The "BCB-sarcomes" Database: the Database of the French Sarcoma Group Dedicated to the Collection of Clinical and Biological Data for All Sarcomas
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 150,000
- 试验地点
- 3
- 主要终点
- Time to next treatment (TNT)
研究概览
简要总结
The BCB SARCOMES database is a clinical and biological national database dedicated to sarcoma that contains 3 main databases with specific aims: the first is the pathology database (French expert network dedicated to the management of bone sarcomas [RESOS] / French expert network dedicated to the pathology of sarcomas [RREPS]), dedicated to systematic review of mesenchymal tumor diagnostics nationwide; the second is clinical (RESOS / French expert clinical network for sarcomas [NETSARC]), collecting multidisciplinary tumor boards (MDTB) data of patients nationwide, and the third (CONTICABASE / BONE / GIST) is dedicated to collecting patients longitudinal/follow up data, with a focus on treatments of every events, and a catalogue of associated samples.
Primary objectives of BCB-SARCOMES are the following: description of the patterns of care and treatment outcomes, assessment of the prognostic factors of patients' outcomes.
With the financial support of the French National Cancer Institute [Institut National du cancer [INCa]).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Patients with sarcoma
Patients with a sarcoma diagnosed in a French Comprehensive cancer Center
干预措施: Chemotherapy (Drug)
Patients with sarcoma
Patients with a sarcoma diagnosed in a French Comprehensive cancer Center
干预措施: Immunotherapeutic Agent (Drug)
Patients with sarcoma
Patients with a sarcoma diagnosed in a French Comprehensive cancer Center
干预措施: target treatment (Drug)
Patients with sarcoma
Patients with a sarcoma diagnosed in a French Comprehensive cancer Center
干预措施: Surgery (Procedure)
Patients with sarcoma
Patients with a sarcoma diagnosed in a French Comprehensive cancer Center
干预措施: Radiotherapy (Radiation)
结局指标
主要结局
Time to next treatment (TNT)
时间窗: 5 years
Time from the systemic treatment onset to the next treatment or death due to any cause, whichever comes first. When neither death nor new systemic therapy is observed, TNT is censored at the date of last patient contact.
Overall survival (OS)
时间窗: 5 years
Interval between diagnosis and the time of death. When death is not observed, OS is censored at the date of last patient contact.
次要结局
未报告次要终点